Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H Aoyama
Norfloxacin Resistance in a Clinical Isolate of Escherichia Coli.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
Mechanisms of Quinolone Resistance in a Clinical Isolate of Escherichia Coli Highly Resistant to Fluoroquinolones but Susceptible to Nalidixic Acid.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
The Response of Escherichia Coli to Ciprofloxacin and Norfloxacin
Journal of Medical Microbiology
Medicine
Microbiology
Imipenem Resistance in Clinical Escherichia Coli From Qom, Iran
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Structural Alteration of OmpR as a Source of Ertapenem Resistance in a CTX-M-15-Producing Escherichia Coli O25b:H4 Sequence Type 131 Clinical Isolate
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Molecular Characterization of Antimicrobial Drug Resistance in Escherichia Coli Isolated From Clinical Samples
International Journal of Current Pharmaceutical Review and Research
Pharmaceutical Science
The Genetic Background of Antibiotic Resistance Among Clinical Uropathogenic Escherichia Coli Strains
Molecular Biology Reports
Medicine
Genetics
Molecular Biology
CTX-M-190, a Novel Β-Lactamase Resistant to Tazobactam and Sulbactam, Identified in an Escherichia Coli Clinical Isolate
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Characterization of a New TEM-type Beta-Lactamase Resistant to Clavulanate, Sulbactam, and Tazobactam in a Clinical Isolate of Escherichia Coli.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Production of KPC-2 Carbapenemase by an Escherichia Coli Clinical Isolate Belonging to the International ST131 Clone
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology